CD34 and diabetes mellitus: Recently, we have shown that TGFβ1 mediates vasoreparative dysfunction in CD34+cells from diabetics and that the transient blockade of the expression of TGFβ1 or PAI-1, the main gene target of TGFβ, restores vasoreparative function.